Official State Health Component Plan definition

Official State Health Component Plan means the document related to Physical Rehabilitation Programs and Services developed by the Department, established by the Georgia Health Strategies Council and signed by the Governor of Georgia.
Sample 1Sample 2Sample 3
Official State Health Component Plan means the document related to Long Term Care Hospitals developed by the Department, established by the Georgia Health Strategies Council and signed by the Governor of Georgia.
Sample 1Sample 2Sample 3
Official State Health Component Plan means the document related to Traumatic Brain Injury Facilities developed by the Department, established by the Georgia State Health Strategies Council and signed by the Governor of Georgia.
Sample 1Sample 2Sample 3

Examples of Official State Health Component Plan in a sentence

  • An applicant for a new or expanded Comprehensive Inpatient Physical Rehabilitation Program for Adults shall document the intent to comply with the Physical Rehabilitation Services and Programs: Definitions and Program Guidelines, as described in the most recent Official State Health Component Plan for Physical Rehabilitation Programs and Services.

  • The training will be provided by the District Office of Human Resources.

  • The need for a new or expanded Traumatic Brain Injury Facility in a service area shall be determined through application of the need method as described in the most recent Official State Health Component Plan for Traumatic Brain Injury Facilities.


More Definitions of Official State Health Component Plan

Official State Health Component Plan means the document related to personal care homes developed by the Department adopted by the State Health Strategies Council, and approved by the Board of Community Health.
Sample 1Sample 2
Official State Health Component Plan means the document related to the above-named services developed by the Agency, established by the Georgia Health Strategies Council, and signed by the Governor of Georgia.
Sample 1
Official State Health Component Plan means the document related to the above-named services developed by the Department, established by the Georgia State Health Strategies Council, and adopted by the Board of Community Health.
Sample 1
Official State Health Component Plan means the document related to specialized cardiovascular services developed by the Department State Health Planning Agency ,established by the Health Strategies Council Georgia State Health Policy Council, and adopted by the Board of Community Health signed by the Governor of Georgia .
Sample 1

Related to Official State Health Component Plan

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Biological safety cabinet means a containment unit suitable for the preparation of low to moderate risk agents where there is a need for protection of the product, personnel, and environment, according to National Sanitation Foundation (NSF) Standard 49.

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Corrective Action Plan has the meaning set forth in Section II.A.2.

  • Non-Participating Clinical Laboratory means a Clinical Laboratory which does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan provide services to you at the time services are rendered.

  • Investigational Medicinal Product means the study drug or control material as defined in the Protocol.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • ug/l means micrograms per liter.

  • Commercial sexual activity means any sex act on account of which anything of value is given to, promised to, or received by any person.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Manufacturing Know-How means, with respect to the Product or any Variant thereof, the technology, data, designs, processes, methods, specifications and other know-how used in connection with the formulation, manufacture, labeling, packaging, quality control, release testing, and production of the Product, and all ingredients used therein and portions thereof.

  • SOUND NATURAL TEETH means teeth that: • are free of active or chronic clinical decay; • have at least fifty percent (50%) bony support; • are functional in the arch; and • have not been excessively weakened by multiple dental procedures. SPECIALTY PRESCRIPTION DRUG is a type of prescription drug listed on our formulary that generally is identified by, but not limited to, features such as: • being produced by DNA technology; • treats chronic or long term disease; • requires customized clinical monitoring and patient support; and • needs special handling.

  • Pivotal Clinical Trial means, with respect to a Licensed Product, (a) a phase 3 Clinical Trial or (b) any other clinical trial that is intended (as of the time the study is initiated) to obtain the results and data to support (without the need to conduct any additional clinical trial) the filing of an application for Regulatory Approval for such product.

  • Physical Therapy Compact Commission or "commission" means the national administrative body whose membership consists of all states that have enacted the compact.

  • Dental laboratory means a person, firm or corporation

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Trauma-informed care means services that are based on an understanding of the vulnerabilities or triggers of those who have experienced violence, that recognize the role violence has played in the lives of those individuals, that are supportive of recovery, and that avoid retraumatization including trauma-focused services and trauma-specific treatment.

  • Anti-Static Product means a product that is labeled to eliminate, prevent, or inhibit the accumulation of static electricity. “Anti-Static Product” does not include “Electronic Cleaner,” “Floor Polish or Wax,” “Floor Coating,” and products that meet the definition of “Aerosol Coating Product” or “Architectural Coating.”

  • Abortion-inducing drug means a drug, medicine, mixture, or preparation, when it is prescribed or administered with the intent to terminate the pregnancy of a woman known to be pregnant.

  • New Drug Application or “NDA” means a new drug application filed with a Regulatory Authority (not including pricing and reimbursement approval), that is analogous to the new drug application with the United States Food and Drug Administration described in 21 C.F.R. § 314.

  • Adopt a comprehensive land use plan means to enact a new

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Certified Remanufacture System or Verified Engine Upgrade means engine upgrades certified or verified by EPA or CARB to achieve a reduction in emissions.

  • FDA means the United States Food and Drug Administration and any successor agency thereto.

  • Drug Master File or “DMF” is described in 21 C.F.R. Part 314.420. A DMF is a submission to the FDA that may be used to provide confidential detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of one or more human drugs.